Align Technology Inc

Company facts

Industry

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Headquarters

Tempe, Arizona

Most recent report

8-K, filed Nov 6, 2026

Incorporated

Delaware

Filings on record

1,000+ filings

On EDGAR

CIK 1097149

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Sep 2026 10-Q

SECSift found 3 of 13 sections worth reading, with 0 positive, 9 notable, and 7 negative flags.

• Financial Statements (Item 1)

  Financial statements and notes with material litigation, tax, and restructuring disclosures.
  Notable

  • Convertible notes of $84.7M held; one borrower is 69% of carrying amount, unsecured, rates up to 10%.
  • Heartland Dental investment carrying value rose to $281.7M as of Sep 30, 2026, from $174M at Dec 31, 2025.
  Negative

  • Accrued $32.7M for antitrust class action settlement; Ninth Circuit reversed summary judgment.
  • Recorded $43.1M liability for UK VAT after losing Upper Tribunal appeal; appealing further.
  • New 2026 restructuring plan initiated in Q3 2026; expects $35-37M total cost, $28.5M recorded so far.

• Management's Discussion (Item 2)

  Contains restructuring, UK VAT liability, tariff impacts, and detailed segment results.
  Notable

  • New $200M manufacturing facility in Hyderabad, India planned, expected to start operations in 2027.
  • Systems & Services revenue fell 7.6% to $175M in Q3 2026, driven by mix shift and lower scanner wand sales.
  • Legal settlements and contingencies totaled $76M for nine months ended Q3 2026, including $43.1M UK VAT.
  Negative

  • UK VAT ruling reversal creates a $43.1M estimated liability as of Q3 2026, with appeals ongoing.
  • Clear Aligner ASP fell 2.4% to $1,215 in Q3 2026 from $1,245 a year ago, driven by product mix shift.

• Risk Factors (Item 1A)

  Company-specific: EU antitrust probe, tariff regime shift, restructuring, and AI regulatory risks.
  Notable

  • Restructuring plan implemented in Q3 2026, the third such plan in three fiscal years, signaling ongoing cost-cutting.
  • 91% of employees are international; immigration policy changes could affect hiring and retention.
  • Five-day in-office mandate since September 2025 may hurt talent retention in a competitive tech labor market.
  • EU AI Act obligations phase in from February 2025 through August 2028, with high-risk AI system rules deferred to 2027-2028.
  Negative

  • Section 301 duties on top 60 trade partners began July 24, 2026, with no rate cap or expiration, raising costs for Mexico-made aligners.
  • EU formal antitrust investigation into Invisalign and iTero practices, announced June 29, 2026, could lead to fines or business changes.

What changed: Sep 2026 vs. Jun 2026

About 6% of ALGN's Sep 2026 10-Q is new information. 30 paragraphs were added, 205 changed, and 13 removed. Below are the most important lines SECSift identified.

• Item 1 81
• Item 2 76
• Item 1A 19
• Item 3 4
• Item 4 2
• Item 6 2
• Item 5 1